Suneva launches Regenica Recovery Gel

SUNEVA Medical Inc. has introduced the Regenica® Recovery Gel soothing balm.

 

Specially formulated for fast healing of damaged skin, the product infuses Multipotent Resignaling Complex MRCx TM next-generation growth factor technology with natural anti-inflammatory and calming agents such as arnica, vitamin K, aloe vera, beta-glucan, and SymCalmin®. The Regenica Recovery Gel is part of the popular Regenica product line marketed in the U.S. and Canada.

 

The solution has been uniquely developed for use after common injectable treatments to help patients return more quickly to daily activities and minimize signs of bruising or swelling, according to Suneva chairman and CEO Nicholas L. Teti, Jr.

 

"The growing popularity of aesthetic treatments calls for advanced skin care products that support a rapid and healthy healing process," added Mr. Teti.

 

Several new dermal fillers have been introduced in recent years to replace lost volume in the skin and to shape and sculpt areas showing signs of aging based on data from the American Academy of Dermatology (AAD). Soft-tissue fillers and wrinkle-relaxing injections, both of which enhance the face, were the two most popular cosmetic treatments performed by American Society for Dermatologic Surgery (ASDS) members in 2013 and 2012.

 

Meanwhile, a recent clinical study of patients using Regenica Recovery Gel daily for one week after having cosmetic injections reveals 100% of participants show no signs of bruising as early as the third day or the first follow-up visit. 

 

According to Dr. Ava Shamban, MD, board-certified dermatologist and key investigator in the clinical research, "Regenica Recovery Gel has delivered remarkable results for my patients and created a better treatment experience. Proven effective, 100% of subjects in a clinical study said they would recommend Regenica Recovery Gel to a friend and use the product after their next filler injection."

 

Privately held Suneva also markets Bellafill® in the U.S. and Canada, ArteFill® in Korea and Singapore; and ReFissa® in the U.S.